These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15577127)

  • 21. Evolution of the tissue selective estrogen complex (TSEC).
    Komm BS; Mirkin S
    J Cell Physiol; 2013 Jul; 228(7):1423-7. PubMed ID: 23359290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.
    Härkönen PL; Väänänen HK
    Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selective estrogen receptor modulators].
    Holzgrabe U
    Pharm Unserer Zeit; 2004; 33(5):357-9. PubMed ID: 15497329
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and biological evaluation of SERMs with potent nongenomic estrogenic activity.
    Tobias SC; Qiu J; Kelly MJ; Scanlan TS
    ChemMedChem; 2006 May; 1(5):565-71. PubMed ID: 16892393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs.
    Zhao L; O'Neill K; Diaz Brinton R
    Brain Res Brain Res Rev; 2005 Nov; 49(3):472-93. PubMed ID: 16269315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Cherchez La Femme": Modulation of Estrogen Receptor Function With Selective Modulators: Clinical Implications in the Field of Urology.
    Helo S; Wynia B; McCullough A
    Sex Med Rev; 2017 Jul; 5(3):365-386. PubMed ID: 28372959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB; Polikarpov I; Andricopulo AD
    J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor?
    Khosla S
    Trends Pharmacol Sci; 2003 Jun; 24(6):261-3. PubMed ID: 12823947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
    Min G
    Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol.
    Nelson ER
    Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].
    Terán Dávila J; Teppa Garrán AD
    Ginecol Obstet Mex; 2005 Aug; 73(8):424-35. PubMed ID: 16304968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer, estrogen receptor and ligands.
    Bai Z; Gust R
    Arch Pharm (Weinheim); 2009 Mar; 342(3):133-49. PubMed ID: 19274700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
    Hall JM; McDonnell DP
    Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
    Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
    J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor and the SERM concept.
    Kuiper GG; van den Bemd GJ; van Leeuwen JP
    J Endocrinol Invest; 1999 Sep; 22(8):594-603. PubMed ID: 10532246
    [No Abstract]   [Full Text] [Related]  

  • 39. Light-activated transcription and repression by using photocaged SERMs.
    Shi Y; Koh JT
    Chembiochem; 2004 Jun; 5(6):788-96. PubMed ID: 15174161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and clinical applications of selective estrogen receptor modulators.
    Nath A; Sitruk-Ware R
    Climacteric; 2009 Jun; 12(3):188-205. PubMed ID: 19387883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.